journal article·2024-06-28Open access

Antiviral and Nontoxic Dermal Iron Oxide Nanoparticle/Biopolymer Coatings for Cotton Fabric

Jamilly S. F. Constantino, Iran D. S. de Mesquita, João D. P. Moraes Segundo, Raimundo N. F. Moreira Filho, Ana B. de Araújo, Marcia V. P. Ferreira, José J. A. de Almeida, Gladyane S. da Silva, Francisco F. P. Souza, Marcos Vinicius Lorevice, Fábia K. Andrade, Marisa M. Beppu, Kalyne Almeida Leal, Rodrigo Silveira Vieira

ACS Applied Nano Materials· Volume 7· Issue 12

Abstract

High Resolution Image Download MS PowerPoint Slide In this study, hybrid coating systems comprising biopolymers (chitosan, N-succinyl chitosan, or sodium alginate, and sodium carboxymethylcellulose) and iron oxide nanoparticles (IONPs) were synthesized, and their antiviral activity against the coronavirus as well as their dermal toxicity in rats were evaluated. The hybrid systems were applied as coating surfaces with virucidal properties against the coronavirus. IONPs were synthesized by using the coprecipitation method, with TEM images revealing their crystalline structure and an average size of 5.6 nm. XRD analysis confirmed the predominance of magnetite in the nanoparticles. Zeta potential analysis assessed the suspension stability of the biopolymer-based antiviral solutions at different IONP concentrations (1.4, 2.8, and 4.1 mM). The hybrid systems were designed for coating cotton fabric, and SEM, EDS, and FTIR characterized the coated surfaces. Among the coatings, the N-succinyl chitosan-based (IONPs/NSC) coating showed the lowest iron ion release after 24 h compared to other polymers. The IONPs/NSC hybrid coating achieved 99% antiviral activity within 5 min of contact, and all coatings exhibited 99.9999% antiviral activity against coronavirus within 24 h, while being nontoxic to L929 fibroblast cells after 24 h of exposure. The acute dermal toxicity of the IONPs/NSC hybrid system was evaluated in accordance with OECD guidelines 402, demonstrating safety for topical use. For this, animals were treated with topical applications of increasing doses of IONPs/NSC (1.5, 5, 14, and 40 mg/kg), benzalkonium chloride (750 mg/kg, toxic standard), and saline or white nanoparticle (WN, control group or a polymeric solution without IONPs). Compared to the control group, no clinical or histological changes were observed for the IONPs/NSC groups during the 14-day observation period. Conversely, benzalkonium chloride induced erythema, edema, and histological alterations in rat skin. These coatings show promise for use on protective equipment, with the aim to mitigate the risk of epidemics or pandemics.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Dyeing and Modifying Textile Fibers · Nanoparticles: synthesis and applications · Textile materials and evaluations

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Federal University of Ceará, Fortaleza 60455-760, Brazil

Department of Chemical Engineering, Fortaleza 60455-760, Brazil

Department of Pharmacy, Fortaleza 60430-160, Brazil

Department of Materials Engineering and Bioprocesses, School of Chemical Engineering, University of Campinas, Campinas 13083-852, Brazil

Department of Chemistry, Fortaleza 60455-760, Brazil

Department of Pathology and Forensic Medicine, Fortaleza 60430-160, Brazil

Brazilian Nanotechnology National Laboratory (LNNano), Brazilian Center for Research in Energy and Materials (CNPEM), Campinas 13083-970, Brazil

Funding

Embrapa Agroind??stria Tropical · Funda????o Cearense de Apoio ao Desenvolvimento Cient??fico e Tecnol??gico · Coordena????o de Aperfei??oamento de Pessoal de N??vel Superior · Department of Genetics, Evolution, Microbiology and Immunology, University of Campinas

References (72)

Show source-provided references
1. 10.1016/S2213-2600(21)00213-710.1016/S2213-2600(21)00213-7 ↗
2. 10.3892/mmr.2022.1277910.3892/mmr.2022.12779 ↗
3. 10.1016/j.ejca.2022.04.03610.1016/j.ejca.2022.04.036 ↗
4. 10.1038/s41392-022-00913-310.1038/s41392-022-00913-3 ↗
5. 10.1038/s41392-022-00880-910.1038/s41392-022-00880-9 ↗
6. 10.1016/j.cell.2020.02.05810.1016/j.cell.2020.02.058 ↗
7. 10.1038/s41467-022-28446-x10.1038/s41467-022-28446-x ↗
8. 10.1038/s41586-021-04385-310.1038/s41586-021-04385-3 ↗
9. 10.1016/j.intimp.2021.10816210.1016/j.intimp.2021.108162 ↗
10. 10.1016/j.jhin.2021.06.00210.1016/j.jhin.2021.06.002 ↗
11. 10.1002/adhm.20200097910.1002/adhm.202000979 ↗
12. 10.1021/acsnano.0c0369710.1021/acsnano.0c03697 ↗
13. 10.1016/j.cobme.2021.10036310.1016/j.cobme.2021.100363 ↗
14. 10.33263/BRIAC125.6651666710.33263/BRIAC125.66516667 ↗
15. 10.3390/nano1111311810.3390/nano11113118 ↗
16. 10.1016/j.nantod.2021.10126710.1016/j.nantod.2021.101267 ↗
17. 10.1128/jvi.01626-2110.1128/jvi.01626-21 ↗
18. 10.3390/nano1004080210.3390/nano10040802 ↗
19. 10.1186/s12951-022-01542-210.1186/s12951-022-01542-2 ↗
20. Fernández-Bertólez N. · 2022 · 30310.1007/978-3-030-88071-2_13 ↗
21. 10.1007/s11095-016-1958-510.1007/s11095-016-1958-5 ↗
22. 10.1007/s11051-021-05156-x10.1007/s11051-021-05156-x ↗
23. 10.1111/jace.1786210.1111/jace.17862 ↗
24. 10.1021/acsanm.0c0271310.1021/acsanm.0c02713 ↗
25. 10.1016/j.eurpolymj.2020.10998410.1016/j.eurpolymj.2020.109984 ↗
26. 10.3390/app918393310.3390/app9183933 ↗
27. 10.1016/j.mseb.2023.11641610.1016/j.mseb.2023.116416 ↗
28. 10.3390/md1303113310.3390/md13031133 ↗
29. Farinha I. · 2020 · 4310.1016/B978-0-12-817966-6.00002-9 ↗
30. 10.1515/revce-2015-001610.1515/revce-2015-0016 ↗
31. 10.1021/acsnano.3c0887510.1021/acsnano.3c08875 ↗
32. 10.1007/s00289-021-03781-z10.1007/s00289-021-03781-z ↗
33. 10.1016/j.carbpol.2015.11.00210.1016/j.carbpol.2015.11.002 ↗
34. 10.1016/j.ijbiomac.2023.12698510.1016/j.ijbiomac.2023.126985 ↗
35. 10.1016/j.msec.2020.11093410.1016/j.msec.2020.110934 ↗
36. 10.2147/CCID.S39136010.2147/CCID.S391360 ↗
37. 10.1016/j.jiac.2018.12.00610.1016/j.jiac.2018.12.006 ↗
38. 10.1080/09674845.2017.134736210.1080/09674845.2017.1347362 ↗
39. 10.1016/j.polymer.2016.03.04510.1016/j.polymer.2016.03.045 ↗
40. 10.1093/oxfordjournals.aje.a11840810.1093/oxfordjournals.aje.a118408 ↗
41. International Organization for Standardization · 2021
42. International Organization for Standardization · 2009
43. 10.3109/15376516.2010.50808010.3109/15376516.2010.508080 ↗
44. 10.1007/s10853-018-2641-510.1007/s10853-018-2641-5 ↗
45. 10.1016/j.jmmm.2021.16809010.1016/j.jmmm.2021.168090 ↗
46. 10.1039/c0jm01274b10.1039/c0jm01274b ↗
47. 10.1016/j.rinp.2017.11.00110.1016/j.rinp.2017.11.001 ↗
48. 10.1515/gps-2016-013810.1515/gps-2016-0138 ↗
49. 10.1016/j.jmrt.2019.02.00510.1016/j.jmrt.2019.02.005 ↗
50. Pate K. · 2016 · 29910.1016/B978-0-08-100165-3.00012-7 ↗
51. 10.1016/j.mehy.2021.11075310.1016/j.mehy.2021.110753 ↗
52. 10.1016/j.ijbiomac.2023.12566510.1016/j.ijbiomac.2023.125665 ↗
53. 10.1016/j.apsusc.2023.15811210.1016/j.apsusc.2023.158112 ↗
54. 10.3390/ijms2022580710.3390/ijms20225807 ↗
55. 10.1016/j.foodchem.2023.13709210.1016/j.foodchem.2023.137092 ↗
56. 10.1016/j.carbpol.2021.11787510.1016/j.carbpol.2021.117875 ↗
57. 10.1098/rsos.18222610.1098/rsos.182226 ↗
58. 10.33263/BRIAC125.6046605710.33263/BRIAC125.60466057 ↗
59. 10.3390/jfb1302007110.3390/jfb13020071 ↗
60. 10.1016/j.ejps.2020.10546510.1016/j.ejps.2020.105465 ↗
61. 10.1039/c3ra47542e10.1039/c3ra47542e ↗
62. 10.1016/j.freeradbiomed.2008.05.00410.1016/j.freeradbiomed.2008.05.004 ↗
63. 10.1002/advs.20200350310.1002/advs.202003503 ↗
64. 10.2298/ABS141218006S10.2298/ABS141218006S ↗
65. 10.2147/IJN.S2635510.2147/IJN.S26355 ↗
66. 10.1016/j.ijantimicag.2016.11.01110.1016/j.ijantimicag.2016.11.011 ↗
67. 10.1007/s43188-023-00178-010.1007/s43188-023-00178-0 ↗
68. 10.3390/antibiotics1007078310.3390/antibiotics10070783 ↗
69. 10.1016/j.chemosphere.2019.12562410.1016/j.chemosphere.2019.125624 ↗
70. 10.1539/joh.50.110.1539/joh.50.1 ↗
71. 10.1016/j.sjbs.2015.09.02910.1016/j.sjbs.2015.09.029 ↗
72. 10.3390/ijms16102441710.3390/ijms161024417 ↗